Digital Pathology & AI
This section brings together physician pathologists and allied computational scientists whose work has helped move pathology from glass slides toward connected, quantitative, and increasingly multimodal practice.
Jason D. Hipp
Pathologist, Informatician & Digital Pathology Executive · Mayo Clinic Laboratories
Hipp has worked across federal research, major technology companies, biopharma, and academic pathology. His career has centered on converting pathology data into usable clinical and translational systems, including leadership of clinical informatics at Mayo Clinic.
Editorial significance. His inclusion reflects an unusually broad view of digital pathology as an organizational, data, and clinical discipline rather than only an imaging tool.
Source: Mayo Clinic Laboratories
Liron Pantanowitz
Professor & Chair of Pathology · University of Pittsburgh
Pantanowitz is a leading physician advocate for digital pathology, pathology informatics, cytopathology, and laboratory innovation. His work has helped translate whole slide imaging from a technical possibility into a governed clinical service.
Editorial significance. He represents the leadership and implementation side of digital transformation, where validation, workflow design, education, and patient safety matter as much as algorithm performance.
Source: University of Pittsburgh
Andrey Bychkov
Pathologist & Global Digital Pathology Educator · Open Pathology
Bychkov has combined diagnostic pathology with open education, social media, and international collaboration. He is closely associated with Open Pathology and with research on how pathologists learn, communicate, and build professional networks online.
Editorial significance. His profile shows that digital pathology is also a culture of open knowledge. Adoption depends on communities that can share cases, methods, and practical experience across borders.
Sources: Open Pathology · PubMed
Anil V. Parwani
Professor & Chair of Pathology · The Ohio State University
Parwani is a surgical pathologist and informatics leader whose work spans digital workflow, computational pathology, laboratory information systems, quality, and education. He has helped build academic programs that connect clinical operations with technology development.
Editorial significance. His career illustrates how a department can make digital pathology part of its core infrastructure instead of treating it as a separate research project.
Source: The Ohio State University
David J. Pisapia
Neuropathologist & Computational Pathology Collaborator · Weill Cornell Medicine
Pisapia practices neuropathology while contributing to digital and computational approaches for brain tumor diagnosis and research. His work sits at the interface of morphology, molecular classification, image analysis, and clinically grounded data science.
Editorial significance. Credible computational pathology needs subspecialists who can define the biological question, curate the tissue evidence, and judge whether an algorithm is clinically meaningful.
Sources: Weill Cornell Medicine · VIVO
Daniel J. Brat
Chair & Pathologist in Chief · Northwestern Medicine
Brat is a neuropathologist known for integrating morphology with molecular classification in diffuse gliomas. His research and leadership have also supported computational approaches to the tumor microenvironment and the interpretation of complex brain tumors.
Editorial significance. His profile demonstrates that artificial intelligence becomes valuable when it is anchored in disease biology, standardized classification, and expert clinical interpretation.
Source: Northwestern University
Thomas J. Fuchs
Chief AI Officer · Eli Lilly · Computational Pathology Scientist
Fuchs is a machine learning scientist rather than a physician pathologist. He built influential programs in computational pathology and digital health at Memorial Sloan Kettering and Mount Sinai before becoming Lilly's first Chief AI Officer in 2024.
Editorial significance. Included as an allied leader whose work helped establish modern pathology AI, while his professional classification is kept explicit.
Source: Eli Lilly
Faisal Mahmood
Associate Professor of Pathology · Harvard Medical School / BWH · Computational Scientist
Mahmood leads a computational pathology laboratory at Brigham and Women's Hospital. His group develops weakly supervised, multimodal, and foundation model approaches — including UNI, CONCH, and TITAN — for diagnosis, prognosis, and biomarker discovery from pathology data.
Editorial significance. A PhD computational scientist, not a medically qualified pathologist. His inclusion recognizes methodological work that has expanded what whole slide images can contribute to precision oncology.
Source: Mahmood Lab, Harvard
David R. J. Snead
Consultant Pathologist & Digital Pathology Pioneer · University Hospitals Coventry and Warwickshire
Snead led one of the best-known early programs for routine digital histopathology in the United Kingdom. His work has emphasized validation, service redesign, and the practical use of digital images for primary diagnosis at scale.
Editorial significance. His importance lies in implementation evidence. The field needed proof that digital diagnosis could function safely and efficiently in a real laboratory, not only in demonstrations.
Sources: West Midlands Secure Data Environment · PubMed
Nasir M. Rajpoot
Professor of Computational Pathology · University of Warwick
Rajpoot is a computer scientist whose group develops artificial intelligence for histology, spatial tissue analysis, and cancer outcome prediction. He has helped build large academic and industry collaborations around computational pathology in the United Kingdom.
Editorial significance. Included as an allied computational leader. His work exemplifies how engineering, data infrastructure, and clinical partnerships can create a durable research ecosystem.
Source: University of Warwick
Surgical Pathology
These profiles emphasize diagnostic authority, classification, education, and the institutional work required to make subspecialty surgical pathology reliable at scale.
David G. B. Klimstra
Professor of Pathology · Yale School of Medicine
Klimstra is an oncologic pathologist with major contributions to gastrointestinal, pancreatobiliary, and neuroendocrine tumor pathology. After a long career at Memorial Sloan Kettering, he joined Yale, bringing diagnostic and departmental leadership experience to a new academic setting.
Editorial significance. His profile represents the consultative authority that helps convert rare and complex tumor patterns into reproducible classifications.
Source: Yale School of Medicine
Jerad M. Gardner
Dermatopathologist, Soft Tissue Pathologist & Educator · Geisinger
Gardner is widely known for case-based teaching in bone, soft tissue, and skin pathology. He used open digital platforms to make high-quality pathology education available well beyond the walls of a single training program.
Editorial significance. His editorial significance comes from combining diagnostic expertise with an accessible teaching style. He helped show that professional reach can be built through generous, accurate, and sustained public education.
Source: Geisinger Medical Laboratories
Kamran M. Mirza
Professor of Pathology & Digital Medical Educator · University of Michigan
Mirza is a hematopathologist and educator who has developed influential digital learning projects, including PathElective and the PathPresenter education ecosystem. His work connects curriculum design, open access resources, and professional community building.
Editorial significance. Modern surgical pathology leadership also involves redesigning how trainees encounter cases, feedback, and subspecialty expertise.
Source: University of Michigan
Mahul B. Amin
Senior Pathology Executive & GU Pathology Authority · Labcorp
Amin has held major academic and professional leadership roles while contributing to genitourinary tumor classification, cancer staging, and diagnostic education. As lead editor of the AJCC Cancer Staging Manual (8th edition), his work connected specialty pathology with standards used across oncology.
Editorial significance. Profiled once; cross-referenced in Genitourinary Pathology. His influence spans both surgical pathology and site-specific classification.
Source: Labcorp
Esther Diana Rossi
Professor of Pathology & Cytopathology Leader · Catholic University of the Sacred Heart, Rome
Rossi is known for thyroid and salivary gland cytopathology, standardized reporting systems, molecular testing, and international professional leadership. Her work helps small samples carry clear, management-relevant meaning across diverse health systems.
Editorial significance. Her profile reflects the value of international consensus. A classification becomes clinically useful only when pathologists, clinicians, and institutions can apply it consistently.
Source: International Academy of Cytology
Christopher D. M. Fletcher
Soft Tissue Pathologist · Brigham and Women's Hospital / Dana-Farber · 1958–2024
Fletcher was one of the defining soft tissue pathologists of his generation. At Brigham and Women's Hospital, he built an internationally recognized consultation practice and shaped WHO tumor classification across multiple editions. He died on 28 July 2024, aged 66.
Editorial significance. His legacy rests on diagnostic clarity, disciplined classification, and the training of a global community of soft tissue pathologists.
Source: Brigham and Women's Hospital
Richard A. Scolyer
Melanoma Pathologist & Researcher · Melanoma Institute Australia · 1966–2026
Scolyer was a globally influential melanoma pathologist and research leader at Melanoma Institute Australia. With Georgina Long, he helped reshape melanoma diagnosis and treatment, and was named joint Australian of the Year in 2024. He died from glioblastoma on 7 June 2026, aged 59.
Editorial significance. His career joined pathology, translational research, public leadership, and unusual personal courage in the face of terminal illness.
Source: The Guardian
Cristina Magi-Galluzzi
Robert and Ruth Anderson Endowed Chair in Pathology · University of Alabama at Birmingham
Magi-Galluzzi is a genitourinary pathologist whose work focuses on prostate, bladder, kidney, testis, and adrenal disease, with particular attention to tumor markers and molecular tests. She became Chair of UAB Pathology in 2024.
Editorial significance. Her profile shows how deep subspecialty expertise can develop into institutional leadership without losing its connection to diagnostic service, teaching, and translational research.
Source: UAB Heersink School of Medicine
Andrew J. Evans
Pathologist in Chief · Mackenzie Health · Digital Pathology Leader, Canada
Evans is a genitourinary pathologist and a prominent advocate for digital pathology implementation in Canada. His leadership has combined clinical service, professional standards, and the practical modernization of diagnostic workflows at a national level.
Editorial significance. Included for demonstrating that digital transformation is a patient care and governance project, not only a technology purchase.
Source: Diagnexia
Andrew M. Bellizzi
Professor of Pathology and Cell Biology · Columbia University
Bellizzi is a gastrointestinal and hepatopancreatobiliary pathologist recognized for practical, evidence-based use of immunohistochemistry and for highly structured diagnostic teaching. He joined Columbia after a long faculty career at Iowa.
Editorial significance. His profile reflects a central surgical pathology skill: turning a large antibody panel into a focused, clinically coherent differential diagnosis.
Source: Columbia University
Molecular Pathology
The people in this section connect morphology with genomic and molecular evidence. Their careers show how laboratory discovery becomes a clinically usable diagnosis, biomarker, or classification.
Nikhil Patkar
Clinician Scientist, Hematopathology & Molecular Diagnostics · ACTREC, Tata Memorial Centre
Patkar works at Tata Memorial Centre's Advanced Centre for Treatment, Research and Education in Cancer. His research integrates measurable residual disease, molecular testing, and hematologic cancer diagnostics in an Indian tertiary oncology setting.
Editorial significance. Molecular pathology advances when assays are developed around real clinical decisions and then made robust enough for routine use.
Source: ACTREC, Tata Memorial Centre
Kojo S. J. Elenitoba-Johnson
Chair of Pathology and Laboratory Medicine · Memorial Sloan Kettering Cancer Center
Elenitoba-Johnson is a hematopathologist and molecular investigator whose work has clarified the biology of lymphoma and helped develop genomic approaches to hematologic malignancy. He leads one of the world's largest cancer pathology departments.
Editorial significance. His career demonstrates the productive union of diagnostic hematopathology, laboratory discovery, technology platforms, and institutional leadership.
Source: Memorial Sloan Kettering Cancer Center
Elaine S. Jaffe
Senior Investigator · National Cancer Institute, NIH
Jaffe is a foundational figure in modern hematopathology. Her research connected lymphoid morphology with immunology, genetics, and clinical behavior. She played a major role in international lymphoma classification, including the REAL Classification and successive WHO editions.
Editorial significance. Her inclusion recognizes how a durable disease classification is built: close observation, biological evidence, clinical correlation, and repeated international consensus.
Source: National Cancer Institute
Arul M. Chinnaiyan
Professor & Howard Hughes Medical Institute Investigator · University of Michigan
Chinnaiyan is known for discovering recurrent gene fusions in prostate cancer (TMPRSS2-ERG) and for developing transcriptomic and precision oncology approaches that connect laboratory discovery with patient testing across multiple cancer types.
Editorial significance. His work is a model for molecular pathology that begins with an unexpected signal, validates it across specimens, and develops it into a biologically and clinically useful marker.
Source: Howard Hughes Medical Institute
Sanja Dacic
Professor & Vice Chair of Anatomic Pathology · Yale School of Medicine
Dacic is a thoracic pathologist whose work integrates lung tumor morphology, immunophenotype, and molecular alterations. She has contributed to the classification and biomarker-informed diagnosis of thoracic malignancies and international lung pathology guidelines.
Editorial significance. Her profile captures the modern pathologist's role in treatment selection, where precise classification and molecular testing must be interpreted as one diagnostic story.
Source: Yale School of Medicine
John A. J. Iafrate
Molecular Pathologist & Laboratory Leader · Massachusetts General Hospital
Iafrate helped develop and implement genomic testing for solid tumors, including work on targetable rearrangements and broad clinical sequencing (SNaPshot, OncoPanel). His laboratory career has consistently linked assay innovation with routine oncology practice.
Editorial significance. Molecular pathology depends on more than discovery. It requires validated methods, clinical interpretation, and laboratories that can deliver results at scale.
Source: Massachusetts General Hospital
Michael D. Feldman
Interim Dean · Indiana University School of Medicine · Pathologist & Informatician
Feldman is a pathologist with long-standing interests in digital pathology, informatics, biobanking, and translational research. In 2026 he serves as interim dean and interim executive vice president for university clinical affairs at Indiana University.
Editorial significance. His career shows how pathology data, tissue resources, and institutional leadership can support a broader learning health system.
Source: Indiana University School of Medicine
Matthew G. Hanna
Associate Professor of Pathology · University of Pittsburgh
Hanna is a breast pathologist and digital pathology leader with experience in whole slide imaging, computational pathology, workflow validation, and education. His career has moved from Memorial Sloan Kettering to Pittsburgh.
Editorial significance. He represents the generation translating digital pathology from specialist centers into everyday academic practice through evidence, standards, and training.
Source: University of Pittsburgh
Kun Huang
Professor & Chair, Biostatistics and Health Data Science · Indiana University
Huang is a PhD data scientist, not a physician pathologist. His work spans bioinformatics, computational pathology, systems biology, and integrative analysis of cancer data linking images with genomic and clinical variables.
Editorial significance. Included as an allied molecular and computational leader. The distinction between data science leadership and medical pathology practice is retained.
Source: Indiana University School of Medicine
George J. Netto
Chair of Pathology and Laboratory Medicine · University of Pennsylvania
Netto is a genitourinary and molecular pathologist with research interests in biomarkers, genomic alterations, and precision classification of urologic cancers. He has led departments at major academic medical centers and now chairs Penn Pathology.
Editorial significance. His profile demonstrates how molecular evidence can remain anchored in expert morphology while informing prognosis, classification, and targeted treatment.
Source: University of Pennsylvania
Hematopathology
Hematopathology depends on the integration of morphology, immunophenotype, genetics, and clinical context. These profiles highlight leaders who helped build that integrated model.
Attilio Orazi
Professor & Chair of Pathology · Texas Tech University Health Sciences Center El Paso
Orazi is an internationally recognized hematopathologist with particular expertise in myeloid neoplasms and bone marrow pathology. His academic work has contributed to classification, consultation practice, and the education of generations of hematopathologists.
Editorial significance. Included for the disciplined interpretive work that turns marrow morphology, clinical context, and evolving criteria into a defensible diagnosis.
Source: Texas Tech University Health Sciences Center El Paso
Robert P. Hasserjian
Hematopathologist · Massachusetts General Hospital · Professor, Harvard Medical School
Hasserjian is a leading authority on myeloid neoplasms, bone marrow pathology, and international disease classification. His work has helped pathologists navigate the increasingly molecular definitions of myelodysplastic and myeloproliferative disease in the WHO-HAEM5 era.
Editorial significance. His profile highlights the judgment required when new genetic criteria change the boundaries of familiar morphologic categories.
Source: Massachusetts General Hospital
Ahmet Dogan
Chief of Hematopathology · Memorial Sloan Kettering Cancer Center
Dogan is known for diagnostic and molecular work in lymphoma, plasma cell neoplasia, and amyloidosis. He leads a major cancer center hematopathology service that integrates morphology, flow cytometry, cytogenetics, and molecular testing.
Editorial significance. Subspecialty excellence depends on both individual expertise and a laboratory system capable of integrating multiple evidence streams.
Source: Memorial Sloan Kettering Cancer Center
Carlos E. Bueso-Ramos
Professor of Hematopathology · MD Anderson Cancer Center
Bueso-Ramos is an expert in bone marrow and myeloid neoplasms, including acute leukemia, myelodysplastic syndromes, and myeloproliferative disease. His work combines diagnostic practice with biomarker and classification research at one of the world's leading cancer centers.
Editorial significance. His career shows how a high-volume cancer center can generate diagnostic insight from difficult cases while maintaining clinically useful categories.
Source: MD Anderson Cancer Center
Olga Pozdnyakova
Director of Hematopathology · University of Pennsylvania
Pozdnyakova directs hematopathology at Penn and works across bone marrow, lymph node, and hematologic malignancy diagnosis. Her scholarship includes practical diagnostic studies that refine morphology and ancillary testing for MDS and related neoplasms.
Editorial significance. Included as a current service leader whose work represents the daily integration of expert diagnosis, laboratory management, education, and research.
Source: University of Pennsylvania
Cherie H. Dunphy
Hematopathologist, Educator & Author · University of North Carolina (career profile)
Dunphy built a distinguished career in hematopathology and pathology education, including faculty leadership at the University of North Carolina. Her books and teaching helped make flow cytometry and lymph node diagnosis more accessible to trainees and practicing pathologists.
Editorial significance. Current institutional status could not be confirmed from a primary profile; this entry is framed as a documented career and educational legacy.
Source: PubMed search record
Elias Campo
Research Director · Hospital Clínic Barcelona · Hematopathologist
Campo is a leading investigator in lymphoma biology, genomics, and classification. His work on chronic lymphocytic leukemia and other lymphoid neoplasms has linked molecular architecture with diagnostic categories and clinical behavior across international consortia.
Editorial significance. His profile represents the international, team-based science required to update hematologic cancer classification responsibly.
Source: Hospital Clínic Barcelona
Daniel A. Arber
Professor & Chair of Pathology · University of Chicago
Arber is an influential hematopathologist and a major contributor to classification of leukemias and related neoplasms. His work integrates morphology, immunophenotype, cytogenetics, and molecular findings into practical diagnostic systems — including co-chairing the 2016 and 2022 WHO myeloid revisions.
Editorial significance. Classification leadership requires both scientific breadth and attention to whether criteria can be applied reproducibly in clinical laboratories.
Source: University of Chicago
Socorro M. Hidalgo López
Identity verification required
The supplied name could not be matched confidently to an established hematopathologist through institutional, professional society, publication, or registry sources. Search results point to similarly named researchers but not to this exact identity.
Editorial significance. No biography is provided because combining records from different people would create a false profile. A middle name, institution, country, or publication is needed for safe resolution.
Source: PubMed name search
Falko Fend
Professor & Chair of Pathology · University Hospital Tübingen
Fend is a hematopathologist with expertise in lymphoma, molecular tissue diagnostics, and infectious disease pathology. His work includes methods that connect morphology with targeted molecular analysis in routine specimens across European academic practice.
Editorial significance. Included for bridging diagnostic service, molecular technique, and European academic leadership in hematopathology.
Source: University Hospital Tübingen
Dermatopathology
The dermatopathology profiles focus on pattern recognition, clinicopathologic correlation, classification, and the disciplined use of ancillary evidence in some of pathology's most visually demanding diagnoses.
Philip E. LeBoit
Professor of Pathology and Dermatology · University of California San Francisco
LeBoit is a senior dermatopathologist whose diagnostic practice and scholarship have shaped the interpretation of melanocytic lesions, cutaneous tumors, and inflammatory skin disease. He contributed to international tumor classification and built a major consultative dermatopathology program at UCSF.
Editorial significance. His career reflects the value of sustained morphologic scholarship and the consultation experience needed to define difficult boundaries in skin pathology.
Source: University of California San Francisco
Lorenzo Cerroni
Professor of Dermatology · Medical University of Graz
Cerroni is internationally recognized for cutaneous lymphoma and for teaching clinicopathologic diagnosis through influential reference texts. His work has helped clarify entities that require close integration of morphology, phenotype, molecular findings, and clinical presentation.
Editorial significance. Included for making complex lymphoproliferative disease more structured and teachable without reducing it to a single test.
Source: ScienceDirect author profile
Klaus J. Busam
Dermatopathologist · Memorial Sloan Kettering Cancer Center
Busam specializes in melanocytic tumors and difficult skin cancer diagnosis. His consultation work, books, and research have helped refine the use of morphology, immunohistochemistry, and molecular findings in melanoma and its mimics.
Editorial significance. His profile highlights how ancillary testing works best when it is guided by a careful morphologic question rather than used as a substitute for interpretation.
Source: Memorial Sloan Kettering Cancer Center
Dirk M. Elston
Professor & Chair, Dermatology and Dermatologic Surgery · Medical University of South Carolina
Elston is a dermatopathologist, dermatologist, editor, and educator with broad influence across inflammatory and neoplastic skin disease. He has led academic programs and major professional publications in the specialty.
Editorial significance. Included for connecting microscopy with clinical dermatology and for using editorial leadership to strengthen how the specialty teaches and evaluates evidence.
Source: Medical University of South Carolina
Pedram Gerami
Professor of Dermatology and Pathology · Northwestern University
Gerami is known for difficult melanocytic lesion diagnosis and for research on molecular tests — including FISH-based assays — that can support risk assessment and classification. His practice integrates dermatopathology with melanoma-focused clinical care.
Editorial significance. His profile illustrates the cautious translation of genomic assays into a field where false certainty can carry major consequences.
Source: Northwestern University
Heinz Kutzner
German Dermatopathologist & Diagnostic Author · Friedrichshafen (career profile)
Kutzner built an influential career in consultative dermatopathology in Friedrichshafen, Germany. He is widely associated with pattern-based diagnosis, adnexal tumors, melanocytic lesions, and practical dermatopathology texts used by trainees worldwide.
Editorial significance. Current academic or service status was not confirmed from an institutional profile; this entry focuses on his documented diagnostic and educational legacy.
Source: WorldCat author search
Bruce R. Smoller
Director of Dermatopathology · University of Rochester Medical Center
Smoller is a senior dermatopathologist, educator, and former department chair. His work spans inflammatory skin disease, cutaneous neoplasia, textbooks, and the development of academic pathology programs across multiple institutions.
Editorial significance. Included for combining subspecialty authority with sustained institutional leadership — his current profile identifies dermatopathology direction rather than the chair role he left in 2022.
Source: University of Rochester Medical Center
Almut Böer-Auer
Dermatopathologist & Author in Inflammatory Skin Disease · Hamburg
Böer-Auer is known for pattern analysis in inflammatory dermatopathology and for books that guide readers from reaction pattern to specific diagnosis. Her work emphasizes the disciplined description of architecture before disease labeling.
Editorial significance. Diagnostic teaching is strongest when it gives readers a repeatable reasoning method, not only a catalogue of entities.
Source: PubMed
Werner Kempf
Dermatopathologist · Kempf und Pfaltz Histological Diagnostics, Zurich
Kempf is recognized for work on cutaneous lymphomas, pseudolymphomas, and infectious skin disease. His career has included academic collaboration with University Hospital Zurich and specialist diagnostic practice in cutaneous lymphoproliferative disorders.
Editorial significance. His profile represents the clinicopathologic and molecular integration required to separate reactive lymphoid proliferations from true cutaneous lymphoma.
Source: University Hospital Zurich
Michael Piepkorn
Clinical Professor & Melanoma Investigator · University of Washington
Piepkorn trained in dermatology, pathology, and dermatopathology and has spent decades studying melanoma and psoriasis while maintaining diagnostic practice. The University of Washington established an endowed research chair in his honor recognizing his contributions.
Editorial significance. Included for a career that connects patient care, tissue diagnosis, and long-term investigation of melanocytic disease.
Source: University of Washington
Cytopathology
Cytopathology turns small samples into high-consequence clinical decisions. These leaders have shaped fine needle aspiration, standardized reporting, molecular testing, education, and access to screening.
Bin Yang
Medical Director of Molecular Cytopathology · Cleveland Clinic
Yang practices diagnostic cytopathology and gynecologic pathology while directing molecular cytopathology and a cancer epigenetics core laboratory. His work connects small sample morphology with modern ancillary testing, including key contributions to The Paris System for Reporting Urinary Cytology.
Editorial significance. The future of cytopathology depends on preserving cellular interpretation while extracting reliable molecular information from limited material.
Source: Cleveland Clinic
Martha B. Pitman
Director of Cytopathology · Massachusetts General Hospital
Pitman is a leading authority on pancreaticobiliary cytology and the clinical use of fine needle aspiration. She has contributed to reporting guidelines — including the Papanicolaou Society system for pancreatic cysts — that connect cytologic categories with management decisions.
Editorial significance. Her profile shows why standardized language matters. A useful cytology report must communicate risk and next steps, not simply describe cells.
Source: Massachusetts General Hospital
Ritu Nayar
Executive Vice Chair & Director of Cytopathology · Northwestern University
Nayar is a cytopathologist and medical education leader with major contributions to cervical and thyroid cytology, standardized reporting — including lead editorship of the Bethesda System for Reporting Thyroid Cytopathology — and professional training.
Editorial significance. Included for showing how consensus systems, curriculum design, and quality improvement can reinforce one another.
Source: Northwestern University
Dina R. Mody
Professor of Pathology and Genomic Medicine · Houston Methodist
Mody is an influential cytopathologist, laboratory leader, and advocate for women's cancer screening. Her work includes gynecologic cytology, textbooks, professional leadership, and community programs that expand access to breast and cervical screening.
Editorial significance. Her profile places cytopathology in its public health context, where diagnostic expertise has greatest value when patients can reach the service.
Source: Houston Methodist
Britt-Marie E. Ljung
Professor of Pathology · University of California San Francisco
Ljung is a recognized authority on fine needle aspiration and interventional cytopathology, with major interests in breast and thyroid disease and research tissue banking. She helped establish the UCSF FNA program as one of the leading centers for cytology education.
Editorial significance. Cytopathologists can shape the entire diagnostic pathway — from obtaining a representative sample to preserving material for research and molecular testing.
Source: University of California San Francisco
Syed Z. Ali
Professor of Pathology and Radiology · Johns Hopkins University
Ali is internationally associated with thyroid cytopathology and co-edited the Bethesda System for Reporting Thyroid Cytopathology. He also contributed to the Milan System for Salivary Gland Cytopathology. His work has given pathologists and clinicians a shared language for risk and management.
Editorial significance. A well-designed reporting system can change practice globally by making uncertainty explicit and actionable.
Source: Johns Hopkins University
Fernando C. Schmitt
Professor of Pathology · University of Porto · International Cytology Leader
Schmitt works across cytopathology, breast pathology, molecular pathology, and international reporting systems. He has led research at IPATIMUP and served in senior roles within the International Academy of Cytology, including as past president.
Editorial significance. His profile reflects a global view of cytology where common terminology, education, and molecular methods help laboratories with very different resources communicate consistently.
Source: International Academy of Cytology
Zubair W. Baloch
Professor & Director of Endocrine Pathology · University of Pennsylvania
Baloch is an endocrine and head and neck pathologist with major contributions to thyroid fine needle aspiration, standardized terminology, and pathology education. He has helped shape both the Bethesda and Milan reporting systems and guided molecular testing integration.
Editorial significance. Included for translating deep organ-specific knowledge into systems that improve communication across pathology, radiology, surgery, and endocrinology.
Source: University of Pennsylvania
Beatrix Cochand-Priollet
Cytopathologist · Hôpital Cochin and Université Paris Cité
Cochand-Priollet has contributed to thyroid, gynecologic, urinary, and endocrine cytology as well as European professional standards. The supplied surname "Cochand Priest" was corrected to the verifiable form Cochand-Priollet based on her published record.
Editorial significance. Her inclusion reflects the European consensus work that helped modern reporting systems travel across languages and health systems.
Source: PubMed
Ashish Chandra
Consultant Histopathologist & Cytopathologist · Guy's and St Thomas' NHS Foundation Trust
Chandra works in cytopathology and urologic histopathology and has contributed to international reporting systems, training, and professional leadership. He has served as departmental clinical lead and specialty lead in the UK.
Editorial significance. Included for connecting organ-based histopathology with cytology and for helping standardize reporting in practical clinical settings.
Source: Guy's and St Thomas' NHS Foundation Trust
Gastrointestinal & Liver Pathology
This section follows specialists who clarified inflammatory, neoplastic, infectious, and molecular disease across the gastrointestinal tract, liver, pancreas, and biliary system.
Laura W. Lamps
Godfrey Dorr Stobbe Professor & Director of GI Pathology · University of Michigan
Lamps is known for gastrointestinal, hepatic, pancreatic, and infectious disease pathology, education, and patient safety. Her leadership connects subspecialty diagnosis with system-level quality work at one of the country's premier academic medical centers.
Editorial significance. Pathology leadership can improve both what a diagnosis says and how reliably the surrounding care system acts on it.
Source: University of Michigan
Rhonda K. Yantiss
Professor & GI Pathologist · University of Miami · Editor-in-Chief, Modern Pathology
Yantiss is an expert in inflammatory bowel disease, appendiceal and colorectal neoplasia, and diagnostic gastrointestinal pathology. She moved from Weill Cornell to Miami and became Editor-in-Chief of Modern Pathology in 2025.
Editorial significance. Her profile combines diagnostic scholarship, mentorship, and editorial leadership at a point when pathology evidence is becoming more molecular and more quantitative.
Source: USCAP
Elizabeth A. Montgomery
Professor & Vice Chair of Anatomic Pathology · University of Miami
Montgomery is a gastrointestinal and soft tissue pathologist known for practical diagnostic teaching and reference books. Her work makes difficult benign and malignant mimics more approachable to practicing pathologists across all career stages.
Editorial significance. Expert education has its greatest value when it sharpens the decisions made at an ordinary sign-out desk.
Source: University of Miami
Robert D. Odze
GI Pathology Consultant & Former Harvard Professor · Independent Practice
Odze built a major career at Brigham and Women's Hospital in inflammatory bowel disease, Barrett esophagus, dysplasia, and gastrointestinal cancer. He now works through an independent consultation practice at Odze Pathology.
Editorial significance. His influence comes from a pathologist whose diagnostic criteria, books, and courses shaped how gastrointestinal biopsy findings are reported and managed internationally.
Source: Odze Pathology
Gregory Y. Lauwers
Senior Member & Director of GI Pathology · Moffitt Cancer Center
Lauwers is an oncologic gastrointestinal pathologist with particular expertise in upper gastrointestinal and hepatopancreatobiliary tumors. His career has included leadership at MGH, UCSF, and Moffitt, building internationally recognized programs at each.
Editorial significance. Included for translating a large international consultation experience into classification, education, and cancer center practice.
Source: Moffitt Cancer Center
Murray B. Resnick
Pathologist in Chief · Rhode Island Hospital and Brown Health
Resnick is a gastrointestinal pathologist and translational leader who has directed surgical and GI pathology and previously served as Chief of Pathology at PathAI. His career crosses academic medicine and computational pathology industry.
Editorial significance. Included for understanding both the clinical service that generates pathology data and the technology organizations that seek to learn from it.
Source: Brown Health
David N. Lewin
Professor & Director of GI and Hepatic Pathology · Medical University of South Carolina
Lewin is a gastrointestinal, liver, pancreatic, and pulmonary pathologist who has combined subspecialty diagnosis with professional and institutional leadership. He also serves in medical affairs and pathology education roles.
Editorial significance. His profile demonstrates the broad clinical coordination required of a senior pathologist in a multidisciplinary academic center.
Source: Medical University of South Carolina
John R. Goldblum
Chair of Anatomic Pathology · Cleveland Clinic
Goldblum is an authority in both gastrointestinal and soft tissue pathology. He has led a large subspecialized anatomic pathology department and co-authored widely used diagnostic textbooks including "Odze and Goldblum's Surgical Pathology of the GI Tract."
Editorial significance. The combination of high-volume consultation, clear teaching, and department design can influence how an entire generation approaches difficult surgical pathology.
Source: Cleveland Clinic
Hanlin L. Wang
Vice Chair & Director of GI and Liver Pathology · UCLA
Wang leads gastrointestinal pathology at UCLA and studies diagnostic, therapeutic, and prognostic biomarkers across gastrointestinal, hepatobiliary, and pancreatic disease. His work integrates service leadership with fellowship education.
Editorial significance. Included as a current example of subspecialty practice that connects morphology, biomarkers, and structured training.
Source: UCLA Health
Lysandra Voltaggio
GI and Liver Pathologist · Joint Pathology Center · Adjunct Faculty, Johns Hopkins
Voltaggio is known for gastrointestinal and liver consultation, practical diagnostic education, and books developed with Elizabeth Montgomery. Her career includes more than a decade at Johns Hopkins and current work at the Joint Pathology Center.
Editorial significance. Included for making high-level gastrointestinal pathology accessible through case-based reasoning and carefully illustrated differential diagnosis.
Source: College of American Pathologists
Genitourinary Pathology
The genitourinary profiles trace the evolution of tumor classification, grading, biomarkers, consultation practice, and translational research across prostate, bladder, kidney, testis, and adrenal disease.
Jonathan I. Epstein
Independent Urologic Pathology Consultant · Former Johns Hopkins Professor
Epstein's diagnostic scholarship in prostate and urinary tract pathology has been highly influential, including defining grading criteria, tumor variants, and a large second opinion practice. He resigned from Johns Hopkins in 2024 following reported allegations of professional misconduct.
Editorial significance. A responsible profile holds two facts together: his technical contributions remain important, and current institutional status should not be represented by outdated titles.
Sources: Current professional site · Center for Health Journalism
John N. Eble
Genitourinary Pathologist & Former Chair · Indiana University · 1952–2023
Eble led Indiana University Pathology and made lasting contributions to renal and testicular tumor classification, consultation practice, and academic department building. He died on 21 August 2023, aged 71.
Editorial significance. His legacy is visible in the language and categories used to diagnose genitourinary tumors and in the department he helped shape.
Source: Indiana University School of Medicine
Shaobo Zhang
Associate Scientist in Pathology · Indiana University School of Medicine
Zhang has contributed to molecular and diagnostic research in urologic tumors, including kidney, bladder, prostate, and testicular disease. His work at Indiana University has supported biomarker studies and personalized medicine research in genitourinary oncology.
Editorial significance. Included as an example of the laboratory scientist whose sustained tissue-based research strengthens subspecialty pathology.
Source: Indiana University School of Medicine
Tamara L. Lotan
Rose Lee and Keith Reinhard Professor of Urologic Pathology · Johns Hopkins University
Lotan is a urologic pathologist and translational investigator focused on prostate cancer biomarkers, including genetically validated tissue markers such as PTEN IHC and digital pathology approaches. She also directs research for the Brady Urological Institute.
Editorial significance. Her profile shows how biomarker discovery can move from mechanism to an assay that pathologists can interpret in routine tissue.
Source: Johns Hopkins Medicine
Rajal B. Shah
Dr. Charles T. Ashworth Professor of Pathology · UT Southwestern Medical Center
Shah is a genitourinary pathologist known for prostate and kidney tumor diagnosis, consultation, research, and fellowship education. His scholarship addresses grading, variants, and clinically important diagnostic distinctions in urologic malignancies.
Editorial significance. Included for pairing expert consultation with the teaching structures needed to reproduce that expertise in the next generation.
Source: UT Southwestern Medical Center
Victor E. Reuter
Vice Chair & Director of GU Pathology · Memorial Sloan Kettering Cancer Center
Reuter is a senior oncologic pathologist whose career has shaped the diagnosis of prostate, kidney, bladder, and testicular tumors. He leads genitourinary pathology and fellowship training at Memorial Sloan Kettering.
Editorial significance. His profile reflects the influence of a high-volume cancer center consultant on classification, staging, multidisciplinary care, and specialist training.
Source: Memorial Sloan Kettering Cancer Center
Ming Zhou
Vice Chair for Oncological Pathology & Director of Urological Pathology · Mount Sinai
Zhou is a urologic pathologist, author, and department leader with research on diagnostic markers and precision classification. After serving as Pathologist in Chief at Tufts, he moved to Mount Sinai to direct urological pathology.
Editorial significance. Included for combining practical diagnostic scholarship, extensive textbook work, and leadership across major academic institutions.
Source: Mount Sinai
Mahul B. Amin
Cross-reference — see Surgical Pathology (No. 14)
Amin appears twice in the supplied list. The compendium counts him once among the 99 unique people. His full profile is in Surgical Pathology and covers his work in genitourinary classification, cancer staging, education, and leadership.
Editorial significance. This cross-reference preserves the original category placement without presenting duplicate biographical content.
Source: Labcorp
Donna E. Hansel
Division Head of Pathology and Laboratory Medicine · MD Anderson Cancer Center
Hansel is a urologic pathologist and investigator whose work focuses on bladder cancer invasion, signaling, and translational biomarkers. She has led pathology programs at several major academic centers and joined MD Anderson in 2022.
Editorial significance. Her profile demonstrates how a physician-scientist can connect mechanistic research, subspecialty practice, and the leadership of a very large diagnostic division.
Source: MD Anderson Cancer Center
Peter A. Humphrey
Professor Emeritus & Research Scientist · Yale University
Humphrey is a widely published urologic pathologist and author with particular expertise in prostate cancer. He retired from the directorship of genitourinary pathology at Yale in 2025 and continues in emeritus and research roles.
Editorial significance. Included for a career that helped codify practical prostate pathology through consultation, classification, textbooks, and WHO classification work.
Source: Yale School of Medicine
Breast & Gynecologic Pathology
These profiles show how breast and gynecologic pathology became increasingly subspecialized, biomarker aware, and closely connected to multidisciplinary cancer care.
Stuart J. Schnitt
Chief of Cancer Pathology · Beth Israel Deaconess · Chief of Oncologic Pathology, Dana-Farber
Schnitt is an internationally recognized breast pathologist whose research and diagnostic work span proliferative breast disease, in situ carcinoma, invasive cancer, and multidisciplinary oncology. His leadership includes key roles at Beth Israel Deaconess and Dana-Farber Cancer Institute.
Editorial significance. Included for shaping both the diagnostic criteria and the clinical conversations that guide modern breast cancer care.
Source: Beth Israel Deaconess Medical Center
Edi Brogi
Director of Breast Pathology · Memorial Sloan Kettering Cancer Center
Brogi is a breast pathologist with expertise across benign disease, in situ lesions, invasive carcinoma, treatment response, and difficult consultation. She directs a major breast pathology service and participates in multidisciplinary cancer care.
Editorial significance. Her profile highlights the pathologist's role in giving patients and clinical teams a precise, integrated account of the disease in the tissue.
Source: Memorial Sloan Kettering Cancer Center
Sunati Sahoo
Professor & Leader in Breast Surgical Pathology · UT Southwestern Medical Center
Sahoo specializes in breast disease and has led surgical and breast pathology services at UT Southwestern. Her work includes morphology, immunohistochemistry, neoadjuvant treatment assessment, and diagnostic education across trainees and practicing pathologists.
Editorial significance. Included for the service leadership that turns specialized breast pathology knowledge into consistent reporting across a large hospital.
Source: UT Southwestern Medical Center
Sarah M. Bean
Professor & Section Head, Gynecologic Surgical Pathology · Duke University
Bean practices gynecologic and breast pathology and cytopathology while holding department leadership roles in faculty development and education. She became head of Duke's Gynecologic Surgical Pathology Division in January 2026.
Editorial significance. Her profile shows that mentorship, curriculum, and inclusive faculty development are part of building a strong diagnostic service.
Source: Duke University
Vickie Y. Jo
Associate Professor of Pathology · Harvard Medical School · Brigham and Women's Hospital
Jo is a surgical pathologist and cytopathologist with recognized expertise in head and neck and soft tissue pathology. Her inclusion in this section reflects her broader anatomic pathology practice rather than a primary breast or gynecologic appointment.
Editorial significance. The profile preserves the requested name while clarifying the subspecialty record shown by current institutional sources.
Source: Brigham and Women's Hospital
Marisa R. Nucci
Vice Chair & Senior Leader in Women's and Perinatal Pathology · Brigham and Women's Hospital
Nucci is a gynecologic and soft tissue pathologist with particular expertise in uterine mesenchymal tumors. Her work combines difficult consultation, classification, education, and leadership within women's and perinatal pathology.
Editorial significance. Included for bringing rigorous soft tissue reasoning to gynecologic tumors that often challenge conventional categories.
Source: Dana-Farber Cancer Institute
Esther Oliva
Director of Gynecologic Pathology · Massachusetts General Hospital · Harvard Professor
Oliva is a gynecologic pathologist with research interests in tumors of the female genital tract as well as renal and testicular tumors. She leads gynecologic pathology at MGH and is widely consulted for difficult ovarian, uterine, and mesenchymal cases.
Editorial significance. Her profile reflects the value of concentrated morphologic expertise in rare uterine, ovarian, and mesenchymal tumors.
Source: Massachusetts General Hospital
Anaïs Malpica
Professor of Pathology · MD Anderson Cancer Center
Malpica is a gynecologic pathologist with deep expertise in ovarian, endometrial, mesenchymal, lower genital tract, and peritoneal tumors. Her consultation practice and clinicopathologic studies — including the widely used two-tier serous carcinoma grading system — are influential internationally.
Editorial significance. Included for showing how focused observation of large case series can improve classification and reduce diagnostic ambiguity.
Source: MD Anderson Cancer Center
David J. Dabbs
Chief of Pathology · PreludeDx · Breast Pathology Author
Dabbs retired from UPMC Magee Womens Hospital in 2019 and later joined PreludeDx, where he leads a breast second opinion service. His major books on breast pathology and diagnostic immunohistochemistry remain widely used in training programs worldwide.
Editorial significance. Included for translating decades of diagnostic practice into practical references that help pathologists choose and interpret ancillary stains responsibly.
Source: PreludeDx
Giuseppe Viale
Professor of Pathology · University of Milan · Director of Pathology, European Institute of Oncology
Viale is a leading breast cancer pathologist whose work has influenced biomarker assessment, clinical trials, and international quality standards. He has led pathology at the European Institute of Oncology for decades, shaping global breast cancer trial methodology.
Editorial significance. His profile shows how centralized pathology review and harmonized biomarker methods can strengthen the evidence produced by international breast cancer trials.
Source: European Society for Medical Oncology
Global Pathology Leaders
The supplied global list combines established pathology leaders, educators, and one major oncology collaborator. Where a name could not be uniquely verified, the publication records that limitation rather than inventing a biography.
Geeta K. Vemuganti
Distinguished Pathologist & Scientist · L. V. Prasad Eye Institute, Hyderabad
Vemuganti is an ocular pathologist and stem cell scientist who led ophthalmic pathology and regenerative research at L. V. Prasad Eye Institute and founded the School of Medical Sciences at the University of Hyderabad. She returned to LVPEI in 2025 after superannuation.
Editorial significance. Included for combining diagnostic pathology, regenerative science, and institution building in India.
Source: L. V. Prasad Eye Institute
Sumeet Gujral
Professor of Pathology & Hematopathologist · Tata Memorial Centre, Mumbai
The supplied name "Sumit Gujral" appears to refer to Sumeet Gujral, the verifiable Tata Memorial Centre hematopathologist. His work focuses on lymphoma, bone marrow, flow cytometry, and integrated hematologic cancer diagnosis within one of India's major cancer systems.
Editorial significance. Included for advancing subspecialty hematopathology and training within one of India's major cancer systems. The spelling correction is explicit.
Source: Tata Memorial Centre
P. G. Subramanian
Professor & Laboratory Leader in Hematopathology · Tata Memorial Centre, Mumbai
Subramanian is a hematopathologist whose work integrates flow cytometry, molecular testing, and morphology in leukemia, lymphoma, and related neoplasms. He has also supported specialist education through Tata Memorial programs in hematopathology.
Editorial significance. Included for building clinically integrated hematopathology capacity in a high-volume cancer network.
Source: Tata Memorial Centre faculty record
Usha K. Luthra
Pioneer Indian Cytopathologist & Cancer Prevention Leader · ICMR (career profile)
Luthra is a pioneering Indian cytopathologist associated with cervical and oral cancer prevention, the Indian Council of Medical Research, and the establishment of national cancer prevention infrastructure. She received the Padma Shri and the International Academy of Cytology's Reagan Award.
Editorial significance. Her career shows how cytology can become a population health instrument when screening, research, training, and policy are developed together.
Source: International Academy of Cytology
Kishore G. Banerjee
Clinical Pathologist & Medical Educator · Manipal University College Malaysia
Banerjee is a clinical pathologist and educator known for concise digital teaching through Pathology360. He received an Osmosis Raise the Line faculty award for engaging medical education that makes core pathology concepts accessible to large learner communities.
Editorial significance. Included as an education-focused leader whose reach comes from making core pathology concepts accessible and applying digital tools to serve learners across geographies.
Source: Osmosis
Geetashree Mukherjee
Senior Consultant & Head in Oncopathology · Tata Medical Center, Kolkata
Mukherjee is an oncopathologist with work spanning diagnostic histopathology, cancer biomarkers, tumor immunology, and the tumor microenvironment. Her career includes regional cancer center leadership and collaborative translational research in eastern India.
Editorial significance. Included for building oncopathology capacity and connecting diagnostic service with research in eastern India.
Source: Tata Medical Center affiliation record
Rajendra A. Badwe
Surgical Oncologist & Former Director · Tata Memorial Centre, Mumbai
Badwe is not a pathologist. He is a surgical oncologist and cancer system leader known for breast cancer research, clinical trials, and leadership of Tata Memorial Centre. He is retained because the user supplied him in a global pathology list.
Editorial significance. His inclusion is contextual: pathology advances through close collaboration with oncologists who help define the clinical questions, trials, and treatment decisions that tissue diagnosis must support.
Source: Institute of Cancer Policy
Meenal Garg
Identity verification required
Several medical professionals share this name, including a pathologist in laboratory management and a pediatric neurologist. Public sources did not provide enough institutional detail to determine which person the supplied list intends.
Editorial significance. No career profile is written because merging records would be misleading. An institution, city, qualification, or publication is required to resolve the identity.
Source: General professional search
Pallavi Sahu
Identity verification required
The exact name matches several professionals in unrelated fields including pathology, ophthalmology, geophysics, and medicine. No authoritative source uniquely connects the supplied name to a recognized pathology leadership record.
Editorial significance. A biography is withheld until an institution, location, middle name, or publication can identify the intended person.
Source: General professional search
Rohit Kumar
Identity verification required
Rohit Kumar is too common a name to resolve without further context. Searches return many clinicians and non-medical professionals, but no single institutional pathology profile can be linked safely to the supplied entry.
Editorial significance. The compendium preserves the name and records the evidence gap. A hospital, country, subspecialty, middle name, or publication is needed for a factual profile.
Source: PubMed name search